EyeBio Announces Expansion of Series A to $130 Million, Adva

EyeBio doubles the size of its original Series A raise with an additional $65 million, with new investors Bain Capital Life Sciences, Omega Funds and Vertex Ventures HC joining the round to support accelerated development of its innovative retinal disease pipelineCompletes enrollment of Multiple Ascending Dose phase...

Related Keywords

United Kingdom , London , City Of , United States , Tony Adamis , Christine Brennan , Matt Pera , Bernard Davitian , David Guyer , Bain Capital Life Sciences , Eyebiotech Limited Eyebio , Ventures Fund , Merck Co Inc , Sv Health Investors , Eyebio Eyebiotech , Omega Funds , Vertex Ventures , Multiple Ascending Dose , Eyebiotech Limited , Jeito Capital , Samsara Biocapital , Managing Director , Chief Executive Officer , Chief Scientific Officer , Anti Permeability Mechanism , Age Related Ocular Neovascularization Evaluation ,